Monika Csóka

2.3k total citations
57 papers, 876 citations indexed

About

Monika Csóka is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Monika Csóka has authored 57 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Monika Csóka's work include Acute Lymphoblastic Leukemia research (20 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Sarcoma Diagnosis and Treatment (13 papers). Monika Csóka is often cited by papers focused on Acute Lymphoblastic Leukemia research (20 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Sarcoma Diagnosis and Treatment (13 papers). Monika Csóka collaborates with scholars based in Hungary, United States and Italy. Monika Csóka's co-authors include Gábor Kovács, Miklós Szendrői, Márta Hegyi, Anne Uyttebroeck, Zoltàn Sápi, Anna Sebestyén, Ágnes F. Semsei, Marta Pillon, Aks Chiang and József Zsíros and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Monika Csóka

50 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika Csóka Hungary 15 339 266 229 183 164 57 876
Roberta Burnelli Italy 17 226 0.7× 204 0.8× 386 1.7× 106 0.6× 113 0.7× 40 838
Katsumichi Fujimaki Japan 19 330 1.0× 171 0.6× 303 1.3× 123 0.7× 153 0.9× 85 1.1k
M. Testi Italy 19 244 0.7× 289 1.1× 167 0.7× 37 0.2× 174 1.1× 62 983
Giuseppina Massini Italy 14 292 0.9× 234 0.9× 346 1.5× 73 0.4× 120 0.7× 39 805
Cyrus Sayehli Germany 14 499 1.5× 218 0.8× 231 1.0× 73 0.4× 245 1.5× 37 831
Blanca Sánchez‐González Spain 20 304 0.9× 721 2.7× 381 1.7× 101 0.6× 144 0.9× 70 1.5k
Jacques Otten Belgium 17 237 0.7× 177 0.7× 260 1.1× 456 2.5× 85 0.5× 35 989
James Dalton United States 8 210 0.6× 550 2.1× 228 1.0× 646 3.5× 105 0.6× 14 1.3k
Dina Attias Israel 16 218 0.6× 169 0.6× 205 0.9× 55 0.3× 210 1.3× 46 864
Fumihiko Ishimaru Japan 21 309 0.9× 249 0.9× 102 0.4× 84 0.5× 329 2.0× 93 1.1k

Countries citing papers authored by Monika Csóka

Since Specialization
Citations

This map shows the geographic impact of Monika Csóka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Csóka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Csóka more than expected).

Fields of papers citing papers by Monika Csóka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Csóka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Csóka. The network helps show where Monika Csóka may publish in the future.

Co-authorship network of co-authors of Monika Csóka

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Csóka. A scholar is included among the top collaborators of Monika Csóka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Csóka. Monika Csóka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lueza, B., Anne Aupérin, Charlotte Rigaud, et al.. (2023). Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma. The European Journal of Health Economics. 25(2). 307–317. 2 indexed citations
3.
Micsík, Tamás, Tamás Tornóczky, Levente Kuthi, et al.. (2023). Alterations of miRNA Expression in Diffuse Hyperplastic Perilobar Nephroblastomatosis: Mapping the Way to Understanding Wilms’ Tumor Development and Differential Diagnosis. International Journal of Molecular Sciences. 24(10). 8793–8793. 5 indexed citations
4.
Garami, Miklós, et al.. (2023). Recent Advances in Paediatric Dermatology Treatments: A Summary. 99(5). 342–354. 1 indexed citations
5.
Krencz, Ildikó, et al.. (2022). In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma. Pathology & Oncology Research. 28. 1610231–1610231. 4 indexed citations
6.
Taj, Mary, Britta Maecker‐Kolhoff, Rebecca E. Ling, et al.. (2021). Primary post‐transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. British Journal of Haematology. 193(6). 1178–1184. 10 indexed citations
7.
Krencz, Ildikó, Noémi Nagy, Gábor Petővári, et al.. (2020). Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma. Cancers. 12(7). 1947–1947. 8 indexed citations
8.
Reusz, György, Orsolya Cseprekál, Éva Kis, et al.. (2020). Distance measurement for pulse wave velocity estimation in pediatric age: Comparison with intra-arterial path length. Atherosclerosis. 303. 15–20. 10 indexed citations
9.
Buglyó, Gergely, et al.. (2019). Quantitative RT-PCR-based miRNA profiling of blastemal Wilms’ tumors from formalin-fixed paraffin-embedded samples. Journal of Biotechnology. 298. 11–15. 11 indexed citations
10.
Farkas, Tamás, Judit Müller, Dániel J. Erdélyi, Monika Csóka, & Gábor Kovács. (2017). Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia. Pathology & Oncology Research. 23(4). 889–897. 5 indexed citations
11.
Sápi, Zoltàn, Miklós Garami, G Papp, et al.. (2017). The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors. Pathology & Oncology Research. 25(1). 217–224. 14 indexed citations
12.
Hegyi, Márta, Ádám Arany, Ágnes F. Semsei, et al.. (2016). Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma. Oncotarget. 8(6). 9388–9398. 34 indexed citations
13.
Белогурова, М. Б., Miklós Garami, Monika Csóka, et al.. (2016). A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma. Cancer Chemotherapy and Pharmacology. 79(1). 155–164. 4 indexed citations
14.
15.
Fritzsching, Benedikt, Jörg Fellenberg, Linda Moskovszky, et al.. (2015). CD8+/FOXP3+-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study. OncoImmunology. 4(3). e990800–e990800. 116 indexed citations
16.
Bárdi, Edit, Monika Csóka, Ildikó Garai, et al.. (2013). Value of FDG-PET/CT Examinations in Different Cancers of Children, Focusing on Lymphomas. Pathology & Oncology Research. 20(1). 139–143. 6 indexed citations
17.
Mann, G. Bruce, A Rosolen, Keizo Horibe, et al.. (2012). Abstracts. British Journal of Haematology. 159(s1). 1–73. 1 indexed citations
18.
Hegyi, Márta, Ágnes F. Semsei, Zsuzsanna Jakab, et al.. (2012). Good prognosis of localized osteosarcoma in young patients treated with limb‐salvage surgery and chemotherapy. Pediatric Blood & Cancer. 58(4). 654–654. 7 indexed citations
19.
Haltrich, Irén, Monika Csóka, Gábor Kovács, et al.. (2012). Six Cases of Rare Gene Amplifications and Multiple Copy of Fusion Gene in Childhood Acute Lymphoblastic Leukemia. Pathology & Oncology Research. 19(1). 123–128. 7 indexed citations
20.
Kovács, Gábor G., et al.. (2008). Lymphomák adoleszcens korban: Érdemes-e gyermek-protokollal kezelni ezt a betegcsoportot?. PubMed. 52(4). 357–362. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Burnelli Breakdown of academic impact, for papers by Katsumichi Fujimaki Breakdown of academic impact, for papers by M. Testi Breakdown of academic impact, for papers by Giuseppina Massini Breakdown of academic impact, for papers by Cyrus Sayehli Breakdown of academic impact, for papers by Blanca Sánchez‐González Breakdown of academic impact, for papers by Jacques Otten Breakdown of academic impact, for papers by James Dalton Breakdown of academic impact, for papers by Dina Attias Breakdown of academic impact, for papers by Fumihiko Ishimaru
Rankless by CCL
2026